News

According to a study funded by Eli Lilly, the trial revealed that participants taking tirzepatide, the drug sold as ...
While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...
Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
Zepbound — the brand name for tirzepatide — is the most effective GLP-1 medication for weight loss, according to one study.
The best metric is not weight, but a particularly toxic kind of fat.
Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...